NCT06550063View on ClinicalTrials.gov

HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes

RecruitingOBSERVATIONAL
Enrollment

2,188

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions
Esophagus CancerGastric CancerHER2-positive CancerHER2-low Cancer
Trial Locations (1)

D08 NHY1

RECRUITING

Trinity St James Cancer Institute, Dublin

All Listed Sponsors
lead

St. James's Hospital, Ireland

OTHER